51MEDIUM

CVB

CURVEBEAM FPO [CVB]
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
Healthcare · ASX Small Cap
$0.0530 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical38
Catalyst52
Sentiment50
Fundamental47
Momentum49
Risk Gate42
Get alerts when CVB's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track CVB — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Drifting lower — down 3.6% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
  • Critical cash runway (1.6 quarters)
  • Low P/S ratio (2.1x)
  • Near 52-week low (1% of range)
  • Small-cap ($20-100M)
  • CANSLIM I: Institutional ownership (21%)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.45%/day)
  • Altman Z-Score distress zone (0.26 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (2/9, low-confidence approx)
  • Deeply negative margins (-133%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about CVB
"What's driving CVB's score?" "How does CVB compare to peers?" "Key risks for CVB?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Initial Director's Interest Notice - Patrick Fisher
NONE Notification regarding unquoted securities - CVB
NONE Independent Non-Executive Director Appointment
LOW CVB to Present at NWR Healthcare Conference

Recent ASX Announcements

2026-03-24 Initial Director's Interest Notice - Patrick Fisher
2026-03-19 CVB to Present at NWR Healthcare Conference
2026-03-18 Notification regarding unquoted securities - CVB
2026-03-18 Independent Non-Executive Director Appointment
2026-02-26 Commentary to App 4D - Dec 2025 Half Year PRICE SENSITIVE

Key Metrics

$25.3M
Market Cap
376K
Avg Volume
1.2x
Vol Ratio
$0.05 — $0.17
52-Week Range
0.2%
Short Interest
N/A
Cash Runway
-41.8%
ROE
-133.1%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 80%
LLeader vs LaggardlaggardRS: -6
IInstitutional SponsorshippassInst: 21%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #26 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:CVB vs ATXCVB vs PNVCVB vs IMM
Scout Pro — Deeper Analysis for CVB
Try Pro free for 30 days
Share this analysis

Track CVB and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required